197 related articles for article (PubMed ID: 9006935)
1. Sp1 is a critical regulator of the Wilms' tumor-1 gene.
Cohen HT; Bossone SA; Zhu G; McDonald GA; Sukhatme VP
J Biol Chem; 1997 Jan; 272(5):2901-13. PubMed ID: 9006935
[TBL] [Abstract][Full Text] [Related]
2. A far upstream cis-element is required for Wilms' tumor-1 (WT1) gene expression in renal cell culture.
Scholz H; Bossone SA; Cohen HT; Akella U; Strauss WM; Sukhatme VP
J Biol Chem; 1997 Dec; 272(52):32836-46. PubMed ID: 9407061
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of colony-stimulating factor-1 promoter activity by the product of the Wilms' tumor locus.
Harrington MA; Konicek B; Song A; Xia XL; Fredericks WJ; Rauscher FJ
J Biol Chem; 1993 Oct; 268(28):21271-5. PubMed ID: 8407965
[TBL] [Abstract][Full Text] [Related]
4. The paired-box transcription factor, PAX2, positively modulates expression of the Wilms' tumor suppressor gene (WT1).
Dehbi M; Ghahremani M; Lechner M; Dressler G; Pelletier J
Oncogene; 1996 Aug; 13(3):447-53. PubMed ID: 8760285
[TBL] [Abstract][Full Text] [Related]
5. Regulation of nov by WT1: a potential role for nov in nephrogenesis.
Martinerie C; Chevalier G; Rauscher FJ; Perbal B
Oncogene; 1996 Apr; 12(7):1479-92. PubMed ID: 8622864
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional regulation of the human Wilms' tumor gene (WT1). Cell type-specific enhancer and promiscuous promoter.
Fraizer GC; Wu YJ; Hewitt SM; Maity T; Ton CC; Huff V; Saunders GF
J Biol Chem; 1994 Mar; 269(12):8892-900. PubMed ID: 8132626
[TBL] [Abstract][Full Text] [Related]
7. Regulation of insulin-like growth factor I receptor gene expression by the Wilms' tumor suppressor WT1.
Werner H; Roberts CT; Rauscher FJ; LeRoith D
J Mol Neurosci; 1996; 7(2):111-23. PubMed ID: 8873895
[TBL] [Abstract][Full Text] [Related]
8. PAX 8 regulates human WT1 transcription through a novel DNA binding site.
Fraizer GC; Shimamura R; Zhang X; Saunders GF
J Biol Chem; 1997 Dec; 272(49):30678-87. PubMed ID: 9388203
[TBL] [Abstract][Full Text] [Related]
9. Repression of the transforming growth factor-beta 1 gene by the Wilms' tumor suppressor WT1 gene product.
Dey BR; Sukhatme VP; Roberts AB; Sporn MB; Rauscher FJ; Kim SJ
Mol Endocrinol; 1994 May; 8(5):595-602. PubMed ID: 8058069
[TBL] [Abstract][Full Text] [Related]
10. Multiple Sp1 binding sites in the cardiac/slow twitch muscle sarcoplasmic reticulum Ca2+-ATPase gene promoter are required for expression in Sol8 muscle cells.
Baker DL; Dave V; Reed T; Periasamy M
J Biol Chem; 1996 Mar; 271(10):5921-8. PubMed ID: 8621466
[TBL] [Abstract][Full Text] [Related]
11. Midkine as a novel target gene for the Wilms' tumor suppressor gene (WT1).
Adachi Y; Matsubara S; Pedraza C; Ozawa M; Tsutsui J; Takamatsu H; Noguchi H; Akiyama T; Muramatsu T
Oncogene; 1996 Nov; 13(10):2197-203. PubMed ID: 8950987
[TBL] [Abstract][Full Text] [Related]
12. Overlapping DNA recognition motifs between Sp1 and a novel trans-acting factor within the wt1 tumour suppressor gene promoter.
Discenza MT; Dehbi M; Pelletier J
Nucleic Acids Res; 1997 Nov; 25(21):4314-22. PubMed ID: 9336463
[TBL] [Abstract][Full Text] [Related]
13. The Wilms' tumor gene product WT1 activates or suppresses transcription through separate functional domains.
Wang ZY; Qiu QQ; Deuel TF
J Biol Chem; 1993 May; 268(13):9172-5. PubMed ID: 8486616
[TBL] [Abstract][Full Text] [Related]
14. Proximal enhancer of the human insulin receptor gene binds the transcription factor Sp1.
Chen H; Walker GE; Taylor SI; McKeon C
Diabetes; 1994 Jul; 43(7):884-9. PubMed ID: 8013752
[TBL] [Abstract][Full Text] [Related]
15. Transcription of the human immunodeficiency virus type 1 (HIV-1) promoter in central nervous system cells: effect of YB-1 on expression of the HIV-1 long terminal repeat.
Sawaya BE; Khalili K; Amini S
J Gen Virol; 1998 Feb; 79 ( Pt 2)():239-46. PubMed ID: 9472608
[TBL] [Abstract][Full Text] [Related]
16. Wilms' tumor 1 splice variants have opposite effects on the tumorigenicity of adenovirus-transformed baby-rat kidney cells.
Menke AL; Riteco N; van Ham RC; de Bruyne C; Rauscher FJ; van der Eb AJ; Jochemsen AG
Oncogene; 1996 Feb; 12(3):537-46. PubMed ID: 8637710
[TBL] [Abstract][Full Text] [Related]
17. Two regulatory proteins that bind to the basic transcription element (BTE), a GC box sequence in the promoter region of the rat P-4501A1 gene.
Imataka H; Sogawa K; Yasumoto K; Kikuchi Y; Sasano K; Kobayashi A; Hayami M; Fujii-Kuriyama Y
EMBO J; 1992 Oct; 11(10):3663-71. PubMed ID: 1356762
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of Wilms tumor WT1 splice variants on the insulin receptor promoter.
Webster NJ; Kong Y; Sharma P; Haas M; Sukumar S; Seely BL
Biochem Mol Med; 1997 Dec; 62(2):139-50. PubMed ID: 9441865
[TBL] [Abstract][Full Text] [Related]
19. GATA-1 transactivates the WT1 hematopoietic specific enhancer.
Wu Y; Fraizer GC; Saunders GF
J Biol Chem; 1995 Mar; 270(11):5944-9. PubMed ID: 7890725
[TBL] [Abstract][Full Text] [Related]
20. Regulation of ornithine decarboxylase gene expression by the Wilms' tumor suppressor WT1.
Moshier JA; Skunca M; Wu W; Boppana SM; Rauscher FJ; Dosescu J
Nucleic Acids Res; 1996 Mar; 24(6):1149-57. PubMed ID: 8604351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
